本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Irhythm Technologies Inc.

169.85
-0.1300-0.08%
成交量:18.42万
成交额:3,139.56万
市值:54.57亿
市盈率:-57.97
高:172.00
开:167.28
低:167.28
收:169.98
52周最高:172.59
52周最低:55.92
股本:3,212.78万
流通股本:3,174.58万
量比:0.73
换手率:0.58%
股息:- -
股息率:- -
每股收益(TTM):-2.9300
每股收益(LYR):-3.6315
净资产收益率:-91.13%
总资产收益率:-3.53%
市净率:52.64
市盈率(LYR):-46.77

数据加载中...

公司资料

公司名字:
Irhythm Technologies Inc.
交易所:
NASDAQ
成立时间:
2006
员工人数:
2000
公司地址:
699 8th Street,Suite 600,San Francisco,California,United States
邮编:
94103
电话:
传真:
- -
简介:
iRhythm Technologies, Inc.于2006年9月14日在美国特拉华州注册成立。公司是一个商业级的数字医疗保健公司重新定义心律失常在临床上通过基于云的数据分析和机器学习能力相结合可穿戴技术,生物传感诊断的方式。公司于2009年继美国食品和药物管理局的间隙在美国开始商业化推出其产品。

董事

名称
职位
Abhijit Y. Talwalkar
Chairman of the Board
Quentin S. Blackford
Director, President and Chief Executive Officer
Brian B. Yoor
Independent Director
Bruce G. Bodaken
Independent Director
Cathleen Noel Bairey Merz
Independent Director
Karen Ling
Independent Director
Karen McGinnis
Director
Kevin O'Boyle
Director

股东

名称
职位
Quentin S. Blackford
Director, President and Chief Executive Officer
Daniel G. Wilson
Chief Financial Officer
Marc Rosenbaum
Senior Vice President, Finance and Chief Accounting Officer
Chad Patterson
Chief Commercial Officer
Mervin Smith
Executive Vice President, Business Operations
Minang Turakhia
Chief Medical Officer, Chief Scientific Officer and Executive Vice President, Product Innovation
Patrick M. Murphy
Chief Business Officer and Chief Legal Officer
Sumi Shrishrimal
Executive Vice President and Chief Risk Officer